Brief: Erytech Pharma SA Reports Cash Position Of EUR 58.6 Million At End Of Q1 2020
May 6 (Reuters) - Erytech Pharma SA ERYP.PA :
* ERYTECH PHARMA SA - CASH POSITION OF EUR 58.6 MILLION
($64.6
MILLION) AT END OF Q1 2020
* ERYTECH PHARMA SA - INTERIM SUPERIORITY ANALYSIS FOR
TRYBECA-1
PHASE 3 TRIAL EXPECTED AROUND YEAR-END AND FINAL ANALYSIS IN 2H
OF 2021
Source text for Eikon: ID:nGNX8Vk7wP
Further company coverage: ERYP.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phaxiam Therapeutics SA
See all newsBrief: Phaxiam Therapeutics Announces The Suspension Of Trading In Its Shares Until Delisting
Brief: Phaxiam Therapeutics Announces Judicial Liquidation And Delisting
Brief: Phaxiam Therapeutics Says Postponement Of The Offer Review Hearing
Brief: Phaxiam Therapeutics Announces Launch Of Process To Find Buyers In Context Of Its Receivership Procedure
Brief: Phaxiam Therapeutics Says Commercial Court Of Lyon To Open Judicial Receivership Procedure